TY - JOUR
T1 - Depressive symptoms and sex differences in the risk of post-COVID-19 persistent symptoms
T2 - a prospective population-based cohort study
AU - Matta, Joane
AU - Pignon, Baptiste
AU - Kab, Sofiane
AU - Wiernik, Emmanuel
AU - Robineau, Olivier
AU - Carrat, Fabrice
AU - Severi, Gianluca
AU - Touvier, Mathilde
AU - Blanché, Hélène
AU - Deleuze, Jean François
AU - Gouraud, Clément
AU - Ouazana Vedrines, Charles
AU - Pitron, Victor
AU - Tebeka, Sarah
AU - Ranque, Brigitte
AU - Hoertel, Nicolas
AU - Goldberg, Marcel
AU - Zins, Marie
AU - Lemogne, Cédric
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2024.
PY - 2024/9/1
Y1 - 2024/9/1
N2 - Women are unexplainedly more affected than men by post-COVID-19 persistent symptoms. Depressive symptoms may partially explain these sex differences. In the French population-based CONSTANCES cohort, depressive symptoms were measured with the nine-item Patient Health Questionnaire between April 6 and May 4, 2020. Between December 2020 and January 2021, among 2,093 infected participants (mean (s.d.) age, 43.0 years (11.9); 55.3% women), 453 (21.6%) reported ≥1 new persistent symptom that emerged from March 2020. Accounting for several confounders, women were more likely than men to have ≥1 symptom (odds ratio (95% confidence interval), 1.45 (1.17–1.80)). Further adjusting for the nine-item Patient Health Questionnaire, participants in the highest (versus lowest) quartile were more likely to have ≥1 symptom (2.97 (2.09–4.23)), while the association with female sex substantially dropped (1.28 (1.02–1.60)). Depressive symptoms mediated 41.5–45.4% of this association. A biopsychosocial model, integrating gender and mental health, is warranted to understand long COVID and inform preventive and therapeutic strategies.
AB - Women are unexplainedly more affected than men by post-COVID-19 persistent symptoms. Depressive symptoms may partially explain these sex differences. In the French population-based CONSTANCES cohort, depressive symptoms were measured with the nine-item Patient Health Questionnaire between April 6 and May 4, 2020. Between December 2020 and January 2021, among 2,093 infected participants (mean (s.d.) age, 43.0 years (11.9); 55.3% women), 453 (21.6%) reported ≥1 new persistent symptom that emerged from March 2020. Accounting for several confounders, women were more likely than men to have ≥1 symptom (odds ratio (95% confidence interval), 1.45 (1.17–1.80)). Further adjusting for the nine-item Patient Health Questionnaire, participants in the highest (versus lowest) quartile were more likely to have ≥1 symptom (2.97 (2.09–4.23)), while the association with female sex substantially dropped (1.28 (1.02–1.60)). Depressive symptoms mediated 41.5–45.4% of this association. A biopsychosocial model, integrating gender and mental health, is warranted to understand long COVID and inform preventive and therapeutic strategies.
UR - http://www.scopus.com/inward/record.url?scp=85206884664&partnerID=8YFLogxK
U2 - 10.1038/s44220-024-00290-6
DO - 10.1038/s44220-024-00290-6
M3 - Article
AN - SCOPUS:85206884664
SN - 2731-6076
VL - 2
SP - 1053
EP - 1061
JO - Nature Mental Health
JF - Nature Mental Health
IS - 9
M1 - 757685
ER -